Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 243-814-3 | CAS number: 20427-58-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://poisoncentres.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Skin irritation / corrosion
Administrative data
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- February - April 2022
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 022
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- (2021)
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Zinc hydroxide
- EC Number:
- 243-814-3
- EC Name:
- Zinc hydroxide
- Cas Number:
- 20427-58-1
- Molecular formula:
- H2O2Zn
- IUPAC Name:
- zinc hydroxide
- Test material form:
- solid: particulate/powder
- Remarks:
- White powder
- Details on test material:
- Chemical name: Zinc hydroxide
CAS number: 20427-58-1
Batch/Lot number: S4374
Description: White powder
Purity: 99.7 %
Manufacturer/supplier: MP Biomedicals
Expiry date: 30 June 2023
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
Name: Zinc hydroxide
Chemical name: Zinc hydroxide
CAS number: 20427-58-1
Batch/Lot number: S4374
Description: White powder
Purity: 99.7 %
Manufacturer/supplier: MP Biomedicals
Expiry date: 30 June 2023
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: The test item is considered stable when stored under appropriate storage conditions: controlled room temperature (15-25°C, ≤70% relative humidity). The test item is stored in the Pharmacy
of the Test Facility.
The test item will be applied in its original form; no formulation is required. The test item was not already a fine powder, therefore it was ground finely in a mortar and pestle.
OTHER SPECIFICS
- Other relevant information needed for characterising the tested material, e.g. if radiolabelled, adjustment of pH, osmolality and precipitate in the culture medium to which the test chemical is added: test material is a white powder
In vitro test system
- Test system:
- human skin model
- Remarks:
- EpiDerm™ (Source: MatTek, Bratislava, Slovakia) units consist of normal, human-derived epidermal keratinocytes (NHEK) which have been cultured to form a multilayered, highly differentiated model of the human epidermis (0.6 cm2).
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Cell source:
- other: as provided by MatTek Corporation, Bratislava, Slovakia
- Source strain:
- other: human-derived epidermal keratinocytes (NHEK)
- Details on animal used as source of test system:
- Not applicable - EpiDerm™ (Source: MatTek, Bratislava, Slovakia) units consist of normal, human-derived epidermal keratinocytes (NHEK).
- Justification for test system used:
- The EpiDerm™ model has been validated for in vitro irritation testing in multiple laboratories
and accepted by OECD No 439, thus it is considered to be suitable for this study.
This test is designed to predict and classify the skin irritant potential of chemicals/formulations/products/mixtures according to chemical safety regulations, using the
reconstructed human epidermis model EpiDerm™ Model and parameters related to skin
irritation. This method is approved by international regulatory agencies as a replacement for
the identification of irritants / corrosives in the in vivo rabbit skin assay (OECD No. 404) and
is specifically approved as a replacement for the in vivo skin irritation test within OECD No.
439. - Vehicle:
- unchanged (no vehicle)
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EpiDerm™ (Source: MatTek, Bratislava, Slovakia)
- Tissue batch number(s): not specified - EpiDerm™ Model (EPI-200-SIT) kits
- Identification data for the components of the kits:
Assay Medium: Batch numbers: 022422LHC ; Expiry date: 10 March 2022
MTT-100-CON: Batch numbers: 011822MSA ; Expiry date: 22 March 2022
MTT-100-DIL: Batch numbers: 2293733 ; Expiry date: 31 March 2022
MTT-100-EXT: Batch numbers: 121421LHA ; Expiry date: 14 December 2022
5% SDS Solution (TC-SDS-5%): Batch numbers: 081221NMA ; Expiry date: 12 August 2022
DPBS: Batch numbers: 120721MSA ; Expiry date: 07 December 2022
- Delivery date: The date of dispatch written on the package was checked before opening the EpiDerm™ kit. The contents of the package were checked according to the map and instructions provided by the supplier.
- Date of initiation of testing: start of experiment on 1 March 2022
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: 37°C
- Temperature of post-treatment incubation (if applicable): The plates with the test item, negative and positive control treated epidermis units were incubated for 35 minutes (± 1 minute) to the humidified incubator at 37°C with 5 % CO2, in a >95% humidified atmosphere and for the exposure time of 25 minutes (± 0.5 minute) at room temperature (21.5-23.2°C).
REMOVAL OF TEST MATERIAL AND CONTROLS
-Volume and number of washing steps: After the incubation time, the EpiDermTM units were removed and rinsed into clean beakers containing 100 mL of DPBS each (20 times). Any remaining liquid were removed onto an absorbent paper.
- Observable damage in the tissue due to washing: not specified
- Modifications to validated SOP: none
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: final concentration: 300 µL MTT medium (1 mg MTT / ml medium)
- Incubation time: 3 hours (±5 minutes)
- Wavelength: 570nm
The proper status of the instrument was verified by measuring a Verification plate (Manufacturer: Thermo Fisher Scientific, Catalogue Number: 240 72800, Serial Number: 0920-14, Date of calibration: 14 October 2020, calibration is valid until October 2022) at the required wavelength on each day before use.
FUNCTIONAL MODEL CONDITIONS WITH REFERENCE TO HISTORICAL DATA
- Viability:
- Barrier function:
- Morphology:
- Contamination:
- Reproducibility:
NUMBER OF REPLICATE TISSUES: At least three replicates will be used for test item; three replicates will be used for both the negative control and positive control. For additional controls, at least two replicates will be used for NSMTT controls, NSCliving and NSCkilled controls (if nessesary).
CONTROL TISSUES USED IN CASE OF MTT DIRECT INTERFERENCE
Red colour was observed after one hour of incubation of the test item in MTT medium, thus the test material did not interact with MTT. Therefore, additional controls and data calculations were not necessary. The false estimation of viability can be excluded.
As the test item was coloured, two additional test item-treated living tissues were used to determine the non-specific OD value and a non-specific colour percentage (NSCliving%). Results of this non-specific colour determination are shown in Table 1. The mean value for optical density (measured at 570 nm) was 0.006, and the NSCliving % value for the test item was calculated as 0.3%. This value was below 5%, therefore additional data calculation was not necessary.
PREDICTION MODEL / DECISION CRITERIA
The test chemical is identified as requiring classification and labelling according to UN GHS (Category 2 or Category 1) if the mean relative viability of three individual tissues after 60 minutes exposure to the test item and 42 hours post incubation is less or equal (≤) to 50% of the mean viability of the negative controls. In case the test chemical is found to be non-corrosive, and shows tissue viability after exposure and post-treatment incubation is less than or equal (≤) to 50%, the test chemical is considered to be irritant to skin in accordance with UN GHS Category 2. The test item may be considered to be non-irritant to skin in accordance with UN GHS (No Category), if the mean relative viability of three individual tissues after 60 minutes exposure to the test item and 42 hours post incubation is more than (>) 50% of the mean viability of the negative controls.
In case of 45-55% relative viability values, a confirmatory run is suggested according to the OECD No. 439 guideline. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): at least 25 mg of the test item will be applied evenly to the epidermal surface
VEHICLE
- Amount(s) applied (volume or weight with unit): na; no formulation was required
30 µL of positive (5% (w/v) SDS solution) or negative (DPBS) control will be added to each skin unit by using a suitable pipette. Chemicals may be spread gently with the pipette tip in order to cover evenly all the epidermal surface if necessary. - Duration of treatment / exposure:
- The plates with the test item, negative and positive control treated epidermis units will be incubated for 35 minutes (± 1 minute) to the humidified incubator at 37°C with 5 % CO2, in a >95% humidified atmosphere. After 35 minutes, all plates will be removed from the incubator, the plates will be placed them into the sterile hood and will be waited until the period of 60 minutes is completed for the first dosed tissue (35 minutes in incubator and 25 minutes at room temperature).
- Duration of post-treatment incubation (if applicable):
- 42h
- Number of replicates:
- 3
Test system
- Details on study design:
- Pre-incubation (Day [-1])
The appropriate number of wells in an assay plate will be filled with the EpiDerm Assay medium (0.9 mL per well). The epidermis units will be placed with the media below them, in contact with the epidermis into each prepared well and then incubated 1 hour at 37°C in an incubator with 5 % CO2, in a >95% humidified atmosphere. Afterwards the medium will be replaced and continued with overnight pre-incubation.
Application (Day 0)
At least three skin units will be used for each test or control material.
Test Item:
As the test item is solid, first an appropriate amount 25 μL of sterile DPBS will be applied to
the epidermal surface (in order to improve further contact between powder and epidermis) and
then at least 25 mg of the test item will be applied evenly to the epidermal surface. Higher amount of test item may be used in order to properly cover the surface of the EpiDerm™ units (the applied volume will be documented in the raw data and reported). If necessary, the test item may be spread gently on the skin surface with a curved flat spatula or pipette tip (or other appropriate tool) taking care not to damage the epidermis. For sticky materials, viscous pastes or other difficult materials, alternative application methods may be appropriate (and will be documented in the raw data and reported).
Positive and negative controls:
30 µL of positive (5% (w/v) SDS solution) or negative (DPBS) control will be added to each skin unit by using a suitable pipette. Chemicals may be spread gently with the pipette tip in order to cover evenly all the epidermal surface if necessary.
Incubation
The plates with the test item, negative and positive control treated epidermis units will be incubated for 35 minutes (± 1 minute) to the humidified incubator at 37°C with 5 % CO2, in a >95% humidified atmosphere. After 35 minutes, all plates will be removed from the incubator, the plates will be placed them into the sterile hood and will be waited until the period of 60 minutes is completed for the first dosed tissue (35 minutes in incubator and 25 minutes at room temperature). The plate lids and the epidermis units will be identified with the exposure time, the replicate number and the code of the chemicals to be tested.
Rinsing (Day 0)
After the incubation time the EpiDerm™ units will be removed and rinsed into clean beakers containing 100 mL of DPBS each (20 times). Any remaining liquid will be removed onto an absorbent paper.
Incubation (Day 0)
After rinsing, the units will be placed into the plate wells with fresh Assay Medium (0.9 mL/well) below them and then incubated for 24 hours (± 2hours) at 37°C in an incubator with 5 % CO2, in a >95 RH % humidified atmosphere.
Incubation (Day 1)
At the end of the 24 hours incubation period the units will be placed into the plate wells with fresh Assay Medium (0.9 mL/well) below them and then incubated for 18 hours (± 2hours) at 37°C in an incubator with 5 % CO2, in a >95 RH % humidified atmosphere.
MTT test after 42 hours incubation (Day 2)
After the 42 hours incubation, 300 µL MTT medium (1 mg MTT / ml medium) will be added to each well of plate and the skin units will be transferred to the MTT medium (except colour control units which will be incubated in Assay Medium). The lid will be replaced and the plate incubated at 37°C in an incubator with 5 % CO2, in a >95% humidified atmosphere for 3 hours (±5 minutes).
Formazan extraction (Day 2)
MTT will be gently aspirated from all wells (e.g. using a suction pump), then wells will be refilled with DPBS and aspirated. The rinsing will be repeated twice and made sure that tissues are dry after the last aspiration. Inserts will be transferred to new 24-well plates. The inserts will be immersed by gently pipetting 2 mL extractant (solution extractant - MTT-100-EXT) into each insert. The level will rise above the upper edge of the insert, thus completely covering the tissue from both sides. The 24 well plate will be sealed (e.g. with a zip bag) to inhibit the
extractant solution evaporation. Extraction will be performed 2 hours with shaking (~120 rpm) at room temperature. After the extraction period is complete, the inserts will be pierced with an injection needle and allowed the extract to run into the well from which the insert was taken. Afterwards the insert can be discarded. The 24-well plates will be placed on a shaker for 15 minutes until solution is homogeneous in colour. A blank sample containing 2 mL of extracting solution (MTT-100-EXT) will be processed in parallel.
Cell viability measurements (Day 2)
Following the formazan extraction, per each tissue will be transferred 2×200 µL of the blue formazan solution into a 96-well flat bottom microtiter plate. The OD (Absorbance / Optical Density) of the samples will be read in a 96-well plate spectrophotometer, at a wavelength of 570 ± 30 nm, using isopropanol solution (MTT-100-EXT) as blank (at least 5×200 µL).
Results and discussion
In vitro
Results
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 1
- Value:
- 89.8
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Remarks:
- Following exposure to zinc hydroxide, the mean cell viability was 89.8% compared to the negative control. This is above the threshold of 50%, therefore under the condition of this assay the test item was considered as being non-irritant to skin.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In this in vitro Epiderm model test with zinc hydroxide, the results indicate that the test item is non-irritant to the skin.
- Executive summary:
An in vitro skin irritation test was conducted on zinc hydroxide in a reconstructed human epidermis model. The EpiDermTM Model is designed to predict and classify the irritation potential of chemicals by measuring its cytotoxic effect as reflected in the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, Thiazolyl blue; CAS number: 298-93-1) assay. The irritation potential of the test item was evaluated according to the OECD guideline No. 439.
Disks of EpiDerm™ Model (three units) were treated with the test item and incubated for 35 minutes 37°C, 5 % CO2 >95 RH% humidified atmosphere and 25 minutes at room temperature. Exposure of the test item was terminated by rinsing with Dulbecco’s Phosphate Buffered Saline (DPBS). The epidermis units were then incubated at 37°C for 24 hours in an incubator with 5% CO2, in a >95% humidified atmosphere and 18 hours at 37°C in an incubator with 5% CO2, in a >95% humidified atmosphere (after medium change). The viability of each disk was assessed by incubating the tissues for 3 hours with MTT solution at 37°C in an incubator with 5% CO2 protected from light, in a >95% humidified atmosphere. The precipitated formazan crystals were then extracted using extracting solution (Isopropanol) for 2 hours with shaking at room temperature and quantified spectrophotometrically at 570 nm.
The negative control epidermis units were treated with DPBS, whilst the positive control epidermis units were treated with 5% (w/v) sodium dodecyl sulphate (SDS) (three units / control). Two additional disks were used to provide an estimate of colour contribution (NSCliving) from the test item. For each treated tissue, the viability was expressed as a percentage relative to the negative control. If the mean relative viability is less or equal (≤) to 50% of the negative control, the test item is considered to be irritant to skin.
Following exposure with zinc hydroxide, the mean cell viability was 89.8% compared to the negative control. This is above the threshold of 50%, therefore the test item was considered as being non-irritant to skin. The experiment met the validity criteria, therefore the study was considered to be valid.
In conclusion, in this in vitro EpiDermTM model test with zinc hydroxide, the results indicate that the test item is non-irritant to skin.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)